RAPT THERAPEUTICS INC shareholders Q3 2023

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
Orbimed Advisors 1,244,945$20,690,9860.44%
Redmile Group, LLC 427,490$7,104,8840.34%
Cormorant Asset Management, LP 325,000$5,401,5000.32%
Boxer Capital, LLC 300,000$4,986,0000.26%
Polar Asset Management Partners Inc. 469,200$7,798,1040.17%
ALGERT GLOBAL LLC 61,991$1,0300.05%
Virtus ETF Advisers LLC 4,691$77,9640.05%
GSA CAPITAL PARTNERS LLP 30,716$5100.04%
Hennion & Walsh Asset Management, Inc. 40,565$674,1900.04%
UBS OCONNOR LLC 93,816$1,559,2220.04%
External links

This page lists RAPT THERAPEUTICS INC's shareholders in Q3 2023. To view RAPT THERAPEUTICS INC's shareholder history, click here.